CRUK-CCR3086, REC 08/H0903/40

Study Funder: Cancer Research UK

Study Title

HOT-II: Randomised double-blind controlled phase III trial of hyperbaric oxygen therapy in patients suffering long-term adverse effects of radiotherapy for pelvic cancer

Medicine or Vaccine (generic name)

Hyperbaric Oxygen

Funder Identification Number

CCR3086, REC 08/H0903/40

Trial Registry Identification Number(#'s)

NCT01087268

Medical Condition

Pelvic cancer

Phase

Phase 3

Link to study details on the Cancer Research UK Clinical Study Register

Not available

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT01087268

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2008-002152-26

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

July 2019